Connecticut passed a law requiring electronic prescribing of controlled substances (EPCS) as part of Connecticut House Bill 7052, “An Act Preventing Prescription Opioid Diversion and Abuse,”, which is now Public Act 17-131, effective January 1, 2018. EPCS is included in Section 3. According to the Connecticut Department of Consumer Protection, controlled substances are “drugs whose use and distribution are closely monitored because of its abuse potential or risk”, with Schedule I drugs having the highest risk. The goals of EPCS are to improve efficiency and help lower the chances of fraudulently duplicating or modifying paper prescriptions.
Connecticut is joining the ranks of states requiring EPCS, including Maine, Minnesota, New York, Rhode Island, and Virginia. States that currently have legislation in process include Illinois, Massachusetts, New Jersey, North Carolina, and Pennsylvania.